1. Extensive Lung Resection for Nontuberculous Mycobacterial Lung Disease With Multilobar Lesions
- Author
-
Kenji Ogawa, Katsuo Yamada, Masahiro Sano, Yukio Seki, Taku Nakagawa, Mitsuaki Yagi, and Yuta Hayashi
- Subjects
Adult ,Lung Diseases ,Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Mycobacterium Infections, Nontuberculous ,Disease ,030204 cardiovascular system & hematology ,Gastroenterology ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Humans ,Pneumonectomy ,Aged ,Retrospective Studies ,Proportional hazards model ,business.industry ,Retrospective cohort study ,Middle Aged ,respiratory system ,Disease control ,respiratory tract diseases ,Treatment Outcome ,030228 respiratory system ,Lung disease ,Operative time ,Female ,Surgery ,Lung resection ,Outcome data ,Cardiology and Cardiovascular Medicine ,business - Abstract
Nontuberculous mycobacterial lung disease often spreads to multiple lobes, and extensive lung resection (ELR) is sometimes required to control the disease. The safety and feasibility of ELR for nontuberculous mycobacterial lung disease remain unclear, however.This retrospective study included patients with nontuberculous mycobacterial lung disease who underwent adjuvant lung resection. Characteristics were compared between patients who underwent ELR and those who underwent simple anatomic lung resection (SALR). The outcome data were analyzed by a Cox regression analysis.A total of 146 patients underwent ELR (n = 54) or SALR (n = 92). ELR was associated with a longer operative time (306 vs 237 minutes; P.001) and higher incidence of prolonged air leak (17% vs 3.3%; P = .016) than SALR. Rates of mortality, sputum culture conversion (positive to negative), and microbiological recurrence did not differ markedly between the groups. In the multivariate analysis, ELR was not a significant risk factor for an unfavorable outcome after nontuberculous mycobacterial lung disease surgery (hazard ratio, 2.23; 95% confidence interval, 0.82-6.03; P= .11).ELR for nontuberculous mycobacterial lung disease has some drawbacks compared with SALR but seems as safe and feasible as SALR. ELR may provide improved disease control in some cases of nontuberculous mycobacterial lung disease with multilobar lesions.
- Published
- 2021
- Full Text
- View/download PDF